Patients with cancer have a significantly higher risk of COVID-19 infection when compared with people without cancer. The patients who have blood and lung cancer and those who are having anti-cancer treatment are venerable to COVID-19. These types of cancer patients have a higher death rate when compared to other cancer patients. Due to the pandemic, patient care declined and there were delays or cancellations of cancer treatments.
Related Tags: Tumor Immunology and Immunotherapy | Cancer Immunology | Breast Cancer Symposiums | Immunology Therapy for Cancer | Immunology To Treat Cancer | Tumor Congress | Immunotherapy For Adenocarcinoma | Immunity and Cancer | Immunology Cancer Trials | Nature Cancer Immunology | Oncology Summit, 2024 | Cancer Immunology Treatment | Tumor Virology | Coronaviruses | Gynecologic Cancer Meetings | Viral Immunology, Vaccines and Antivirals | Human Virology and Viral Diseases | General Virology | Gynecologic Cancer Meetings | Sars-Cov-2 and Covid-19 | Cancer Cell | All Cancer | Cancer Events
Related Societies: International Gynecologic Cancer Society | International Liver Cancer Association | International Lung Cancer Consortium | International Mesothelioma Interest Group | International Myeloma Foundation | International Myeloma Society | International Society for Gastrointestinal Hereditary Tumours | International Society of Nurses in Cancer Care | International Society of Ocular Oncology | International Society of Oncology Pharmacy Practitioners